PEOPLE - TissueLink Medical (US) makes appointment:
This article was originally published in Clinica
Executive Summary
TissueLink Medical, a privately held US developer of technology for repairing tissue during surgery, has appointed Robert Strauss to the board. Mr Strauss is currently president and CEO of Noven Pharmaceuticals and serves as director of Percardia, Columbia Laboratories and Eclipse Surgical Technologies.